Alopecia Areata of the Beard

A Review of the Literature

Jessica Cervantes, Raymond M. Fertig, Austin Maddy, Antonella Tosti

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Alopecia areata (AA) is a T-cell mediated autoimmune disorder in which inflammatory cells attack the hair follicle, resulting in round, well-circumscribed patches of noncicatricial hair loss in normal appearing skin. AA affecting the beard area is well known and is referred to as AA of the beard (BAA) or AA barbae when involvement is limited exclusively to the beard. BAA has been documented in a select number of studies. We review the literature and discuss the clinical features, epidemiology, diagnosis, and treatment of BAA. Clinical presentation of BAA can vary and manifest as single small areas of hair loss, multiple small or large simultaneous focuses, or total hair loss. Most patients are middle-aged males with focal patches of round or oval hair loss, mostly localized along the jawline. Patches are characteristically well circumscribed and smooth with white hair present at the periphery. Dermoscopic features of BAA include yellow dots, broken hair, and short vellus hairs. BAA may be associated with other autoimmune disorders, including atopic dermatitis, vitiligo, and psoriasis. Many treatment modalities are available for BAA, and selection of a therapy depends on several factors, including disease activity, extent of area affected, duration of disease, and age of the patient. Topical corticosteroids are most commonly used as initial treatment, followed by intralesional steroids. Other therapeutic modalities are discussed.

Original languageEnglish (US)
Pages (from-to)789-796
Number of pages8
JournalAmerican Journal of Clinical Dermatology
Volume18
Issue number6
DOIs
StatePublished - Dec 1 2017

Fingerprint

Alopecia Areata
Alopecia
Hair
Therapeutics
Vitiligo
Hair Follicle
Atopic Dermatitis
Psoriasis
Adrenal Cortex Hormones
Epidemiology
Steroids
T-Lymphocytes
Skin

ASJC Scopus subject areas

  • Dermatology

Cite this

Alopecia Areata of the Beard : A Review of the Literature. / Cervantes, Jessica; Fertig, Raymond M.; Maddy, Austin; Tosti, Antonella.

In: American Journal of Clinical Dermatology, Vol. 18, No. 6, 01.12.2017, p. 789-796.

Research output: Contribution to journalReview article

Cervantes, Jessica ; Fertig, Raymond M. ; Maddy, Austin ; Tosti, Antonella. / Alopecia Areata of the Beard : A Review of the Literature. In: American Journal of Clinical Dermatology. 2017 ; Vol. 18, No. 6. pp. 789-796.
@article{0d8cbb517bae4982ad64749981097284,
title = "Alopecia Areata of the Beard: A Review of the Literature",
abstract = "Alopecia areata (AA) is a T-cell mediated autoimmune disorder in which inflammatory cells attack the hair follicle, resulting in round, well-circumscribed patches of noncicatricial hair loss in normal appearing skin. AA affecting the beard area is well known and is referred to as AA of the beard (BAA) or AA barbae when involvement is limited exclusively to the beard. BAA has been documented in a select number of studies. We review the literature and discuss the clinical features, epidemiology, diagnosis, and treatment of BAA. Clinical presentation of BAA can vary and manifest as single small areas of hair loss, multiple small or large simultaneous focuses, or total hair loss. Most patients are middle-aged males with focal patches of round or oval hair loss, mostly localized along the jawline. Patches are characteristically well circumscribed and smooth with white hair present at the periphery. Dermoscopic features of BAA include yellow dots, broken hair, and short vellus hairs. BAA may be associated with other autoimmune disorders, including atopic dermatitis, vitiligo, and psoriasis. Many treatment modalities are available for BAA, and selection of a therapy depends on several factors, including disease activity, extent of area affected, duration of disease, and age of the patient. Topical corticosteroids are most commonly used as initial treatment, followed by intralesional steroids. Other therapeutic modalities are discussed.",
author = "Jessica Cervantes and Fertig, {Raymond M.} and Austin Maddy and Antonella Tosti",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s40257-017-0297-6",
language = "English (US)",
volume = "18",
pages = "789--796",
journal = "American Journal of Clinical Dermatology",
issn = "1175-0561",
publisher = "Adis International Ltd",
number = "6",

}

TY - JOUR

T1 - Alopecia Areata of the Beard

T2 - A Review of the Literature

AU - Cervantes, Jessica

AU - Fertig, Raymond M.

AU - Maddy, Austin

AU - Tosti, Antonella

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Alopecia areata (AA) is a T-cell mediated autoimmune disorder in which inflammatory cells attack the hair follicle, resulting in round, well-circumscribed patches of noncicatricial hair loss in normal appearing skin. AA affecting the beard area is well known and is referred to as AA of the beard (BAA) or AA barbae when involvement is limited exclusively to the beard. BAA has been documented in a select number of studies. We review the literature and discuss the clinical features, epidemiology, diagnosis, and treatment of BAA. Clinical presentation of BAA can vary and manifest as single small areas of hair loss, multiple small or large simultaneous focuses, or total hair loss. Most patients are middle-aged males with focal patches of round or oval hair loss, mostly localized along the jawline. Patches are characteristically well circumscribed and smooth with white hair present at the periphery. Dermoscopic features of BAA include yellow dots, broken hair, and short vellus hairs. BAA may be associated with other autoimmune disorders, including atopic dermatitis, vitiligo, and psoriasis. Many treatment modalities are available for BAA, and selection of a therapy depends on several factors, including disease activity, extent of area affected, duration of disease, and age of the patient. Topical corticosteroids are most commonly used as initial treatment, followed by intralesional steroids. Other therapeutic modalities are discussed.

AB - Alopecia areata (AA) is a T-cell mediated autoimmune disorder in which inflammatory cells attack the hair follicle, resulting in round, well-circumscribed patches of noncicatricial hair loss in normal appearing skin. AA affecting the beard area is well known and is referred to as AA of the beard (BAA) or AA barbae when involvement is limited exclusively to the beard. BAA has been documented in a select number of studies. We review the literature and discuss the clinical features, epidemiology, diagnosis, and treatment of BAA. Clinical presentation of BAA can vary and manifest as single small areas of hair loss, multiple small or large simultaneous focuses, or total hair loss. Most patients are middle-aged males with focal patches of round or oval hair loss, mostly localized along the jawline. Patches are characteristically well circumscribed and smooth with white hair present at the periphery. Dermoscopic features of BAA include yellow dots, broken hair, and short vellus hairs. BAA may be associated with other autoimmune disorders, including atopic dermatitis, vitiligo, and psoriasis. Many treatment modalities are available for BAA, and selection of a therapy depends on several factors, including disease activity, extent of area affected, duration of disease, and age of the patient. Topical corticosteroids are most commonly used as initial treatment, followed by intralesional steroids. Other therapeutic modalities are discussed.

UR - http://www.scopus.com/inward/record.url?scp=85034435718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034435718&partnerID=8YFLogxK

U2 - 10.1007/s40257-017-0297-6

DO - 10.1007/s40257-017-0297-6

M3 - Review article

VL - 18

SP - 789

EP - 796

JO - American Journal of Clinical Dermatology

JF - American Journal of Clinical Dermatology

SN - 1175-0561

IS - 6

ER -